Skip to main content
SpringerLink
Log in

Anti-CD19-CAR-transduced-T-cells/lenalidomide

Multiple toxicities: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Li C, et al. PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report. Frontiers in Immunology 12: 2021. Available from: URL: http://doi.org/10.3389/fimmu.2021.599493

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anti-CD19-CAR-transduced-T-cells/lenalidomide. Reactions Weekly 1870, 33 (2021). https://doi.org/10.1007/s40278-021-01243-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-01243-y

Search

Navigation